| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/12/2008 | CN100431547C A triptolide composite preparation for treating osteoarthritis by joint intracavity injection |
| 11/12/2008 | CN100431546C Progestational hormone composition, and its slow-release suppository device and preparation of said device |
| 11/12/2008 | CN100431545C Use of compositions comprising an estrogenic component for the treatment and prevention of musculoskeletal pain |
| 11/12/2008 | CN100431544C Formulations of glucocorticoids to treat pathologic ocular angiogenesis |
| 11/12/2008 | CN100431543C Pharmaceutical composition |
| 11/12/2008 | CN100431542C Application of yohimbine and berberine mixture in medicament preparation |
| 11/12/2008 | CN100431541C Phentanyl-containing adhesive patch for application to oral-cavity mucosa |
| 11/12/2008 | CN100431540C Treatment of diabetes with thiazolidinedione and metformin |
| 11/12/2008 | CN100431539C Use of acetylchloinesterase inhibitor for preparing medicine for treating parkinson's disease |
| 11/12/2008 | CN100431538C An anticancer pharmaceutical composition and preparation method thereof |
| 11/12/2008 | CN100431537C Blood fluidity improving agent |
| 11/12/2008 | CN100431536C Alpha 2b 0r 2b/2c adrenoceptor agonists for the treatment of neurodegeneration |
| 11/12/2008 | CN100431535C Chlorhydric acid tranditerol aerosol |
| 11/12/2008 | CN100431534C Methods of inhibiting vascular permeability and apoptosis |
| 11/12/2008 | CN100431533C Medicinal composition containing backuchiol for treating female osteoporosis |
| 11/12/2008 | CN100431532C Breviscapine and borneol constituted composite injection formulation and preparation method thereof |
| 11/12/2008 | CN100431531C Transdermal pharmaceutical spray formulations comprising a vp/va copolymer and a non-aqueous vehicle |
| 11/12/2008 | CN100431530C Soft polyene phosphatidylcholinecapsule and its prepn process |
| 11/12/2008 | CN100431526C A rapidly disintegrating tablet of acid sensitive drug |
| 11/12/2008 | CN100431516C Device for calculating elixir doses approprate for patient's weight |
| 11/12/2008 | CN100431434C Soft drink replacer |
| 11/11/2008 | US7449605 Drugs; therapy for kidney diseases; removal of bile acid; gastrointestinal disorders; core-shell polymer |
| 11/11/2008 | US7449599 Phenyl carboxamide compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 11/11/2008 | US7449595 Nitrosated and nitrosylated prostaglandins, compositions and methods of use |
| 11/11/2008 | US7449594 Process for preparing 4-pentafluorosulfanylbenzoylguanidines |
| 11/11/2008 | US7449589 passing a mobile phase comprising carbon dioxide through a stationary phase comprising a derivatised polysaccharide, and wherein the process is capable of providing at least 0.1 gram of the separated (-)- Delta 9-trans-tetrahydrocannabinol in less than a day |
| 11/11/2008 | US7449585 1,2-dihydro-2-(4-trifluoromethylphenyl)-6-(3-trifluoromethyl-2-pyridinyl)-3H-indazol-3-one; capsaicin receptor ; analgesic, antiinflammatory, hypotensive agent; rheumatoid arthritis, osteoarthritis, headache, migraine, cancer and central nervous system pain, irritable bowel syndrome |
| 11/11/2008 | US7449583 Process for the preparation of 4-(8-chloro-5 6-dihydro-11h-benzo-(5 6)-cyclohepta-(1 2b)-pyridin-11-ylidene-1-piperidiniecarboxylic acid ethyl ester (loratadine) |
| 11/11/2008 | US7449582 particularly tyrosine kinase, serine-threonine kinases, and MAP kinases; cancer, nervous system disorders and autoimmune diseases; 6-phenyl-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidines, 3-phenyl-2-oxo-1,2-dihydro-[1,6]naphthyridines, and 3-phenyl-2-oxo-1,2-dihydroquinolines |
| 11/11/2008 | US7449581 6-Substituted pyrido-pyrimidines |
| 11/11/2008 | US7449575 preparing 4-[[4-amino-6-[(2,6-dichlorophenyl)methyl]-1,3,5-triazin-2-yl]amino]benzonitrile by reacting 2,6-dichlorobenzeneethanimidamide with phenyl N'-cyano-N-(4-cyanophenyl)-carbamimidate in a reaction-inert solvent; HIV (Human Immunodeficiency Virus) infection |
| 11/11/2008 | US7449572 Reducing compound such as 3,3-ethylenedioxyestra-5(10), 9(11)-dien-17-ol, halogenating, epoxidation, alkylation, deprotecting, aromatization, saponification, neutralization to obtain compound such as 11-beta-(4-(2-(1-piperidinyl)ethoxy)phenyl)-17-alpha-fluoroestra-1,3,5(10)-trien-3-ol |
| 11/11/2008 | US7449571 Halogenated aminoquinolines and oligonucleotides containing the same |
| 11/11/2008 | US7449570 Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases |
| 11/11/2008 | US7449565 Chimeric tumor suppressor gene and protein |
| 11/11/2008 | US7449537 Antineoplastic polyalkoxyalkylsiloxanes and methods of use thereof |
| 11/11/2008 | US7449495 e.g. 4-(3-(1-Adamantyl)-4-tert-butyldimethyl-silyloxyphenyl)benzaldehyde; antitumor, antiinflammatory agent; arthritic pathology, metastatisation, diabetic retinopathy, psoriasis, chronic inflammatory disease, and atherosclerosis; sarcoma, carcinoma, carcinoid, leukaemia |
| 11/11/2008 | US7449494 made by the reaction of dimethyl ethanolamine, and tetra 2-hydroxyalkyl ethylene diamne with di-chloro glycerin in water |
| 11/11/2008 | US7449493 N-[2-[[1-[[[(2,4-dimethylphenyl)methyl]amino]methyl]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide; monocyte chemoattractant proteins receptor antagonists or partial agonists/antagonists; antiinflammatory agent, autoimmune diseases; rheumatoid arthritis, multiple sclerosis, atherosclerosis |
| 11/11/2008 | US7449492 Therapeutic agents—I |
| 11/11/2008 | US7449491 Natural vitamin E compositions with superior antioxidant potency |
| 11/11/2008 | US7449490 Pharmaceutically active compounds and methods of use |
| 11/11/2008 | US7449489 e.g. isopropyl [({2-[5-[2-(2-azabicyclo[2.2.2]oct-2-yl)- 1,1-dimethyl-2-oxoethyl]-2-(3,5-dimethylphenyl)-1H-indol-3-yl]propyl }amino)(3-pyridin-4-ylpyrrolidin-1-yl)methylene]carbamate; gonadotrophin releasing hormone antagonists; anticarcinogenic agent; breast, prostate, uretus cancer |
| 11/11/2008 | US7449488 Pyrazolopyrimidines as protein kinase inhibitors |
| 11/11/2008 | US7449487 In particular of avocado, soya bean and/or lupin oils, for preparation of a medicament intended to stimulate expression of TGF-62 or expression of the plasminogen activator inhibitor PAI-1 |
| 11/11/2008 | US7449486 Mitotic kinesin inhibitors and methods of use thereof |
| 11/11/2008 | US7449485 N-sulfonylurea apoptosis promoters |
| 11/11/2008 | US7449484 angiogenesis inhibitor; Tie2 receptor kinase inhibitors; 2-tert-Butyl-4-naphthalen-2-yl-5-pyridin-4-yl-imidazole;2-tert-Butyl-4-(6-Ethoxynaphthalen-2-yl)-5-pyridin-4-yl-imidazole;4-(2-tert-Butyl-5-(6-methoxy-naphthalen-2-yl)-3H-imidazol-4-yl)-pyridine; etc. |
| 11/11/2008 | US7449483 e.g. 2-(Ethyl-{4-[2-methyl-3-(4-trifluoromethyl-phenyl)-benzo[b]thiophen-6-yl]-butyl}-amino)-ethanol; 2,3-oxidosqualene-lanosterol cyclase inhibitor; antidiabetic, antitumor, antiproliferative agent; hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones |
| 11/11/2008 | US7449482 Piperidine compounds useful as malonyl-CoA decarboxylase inhibitors |
| 11/11/2008 | US7449481 Thio-substituted biaryl-methanesulfinyl derivatives |
| 11/11/2008 | US7449480 Small molecule inhibitors of HER2 expression |
| 11/11/2008 | US7449479 Hepatitis C virus inhibitors |
| 11/11/2008 | US7449478 Treatment of peroxisome proliferation activated receptor diseases such as diabetes, skin disorders or high blood pressure |
| 11/11/2008 | US7449477 7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (protein kinase B) |
| 11/11/2008 | US7449476 e.g. 2,3,4,5-tetrahydro-2-[2-[4-methoxy-7-(5-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-5-phenyl-1H-pyrido[4,3-b]indole; inhibit HIV entry by attaching to exterior viral envelop protein gp120 and interrupting viral entry process by interfering with cellular receptor CD4 |
| 11/11/2008 | US7449475 e.g. 2-{[(2S)-3-(5-Chloro-1'H,3H-spiro[1-benzofuran-2,4'-piperidin]-1'-yl)-2-hydroxypropyl]oxy}-N-cyclopropylbenzamide; macrophage inflammatory protein (MIP)-1 alpha chemokine receptor modulator; antiinflammatory, antiproliferative agent, autoimmune diseases |
| 11/11/2008 | US7449474 Tri-substituted ureas as cytokine inhibitors |
| 11/11/2008 | US7449473 8-(1-methyl-1H-pyrrol-2-yl)-1,3-dipropyl-1H-pyrrolo[3,2-d]pyrimidine-2,6-dione; asthma, chronic obstructive pulmonary disorder, emphysema, diabetic disorders, inflammatory gastrointestinal tract disorders, immunological/inflammatory disorders, cardiovascular diseases, neurological disorders |
| 11/11/2008 | US7449472 Methods of inhibiting p38 with substituted bicyclic pyrimidines |
| 11/11/2008 | US7449471 5-phenylpyrimidines, their preparation, compositions comprising them and their use |
| 11/11/2008 | US7449470 Antagonists to treat neurodegenerative diseases like Parkinson's disease; 2,4,6-trisubstituted pyrimidines; N-(2,6-diphenyl-pyrimidin-4-yl)-benzamide |
| 11/11/2008 | US7449469 Improved pharmacological activity and tolerability; glaucoma; ocular hypertension |
| 11/11/2008 | US7449468 Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors |
| 11/11/2008 | US7449467 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 11/11/2008 | US7449466 Cyclic aminophenyl sulfamate derivative |
| 11/11/2008 | US7449465 glycogen synthase kinase 3 alpha and 3 beta inhibitors; improved phanrmacological activity, potency, selectivity, solubility, permeability, metabolic stability; bipolar disorder; Alzheimer's disease; type II diabetes, neuropathic pain; depression; inflammatory diseases |
| 11/11/2008 | US7449464 4-{3-[4-(6-Chlorobenzothiazol-2-yl)-1,4-diazepan-1-ylcarbonyl]benzyl}-1(2H)-phthalazinone; Cancer, BRCA deficient |
| 11/11/2008 | US7449463 Morpholinyl containing benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 11/11/2008 | US7449462 2-{4-[4-(2-Ethyl-phenyl)-5-methyl-4H-[1,2,4]triazol-3-yl]-piperidin-1-yl}-pyrimidine; more potent, longer duration of action, broader range of activity, more stable, fewer side effects, selectivity; anxiety, cardiovascular disease, dysmenorrhoea, endometriosis, emesis, inflammation, sexual disorders |
| 11/11/2008 | US7449461 Benzathiazol-acetamides |
| 11/11/2008 | US7449460 3-Quinolinecarbonitrile protein kinase inhibitors |
| 11/11/2008 | US7449459 Inhibitors of soluble adenylate cyclase |
| 11/11/2008 | US7449458 Prodrugs of 2,4-pyrimidinediamine compounds and their uses |
| 11/11/2008 | US7449457 Substituted heterocyclic carboxamides with antithrombotic activity |
| 11/11/2008 | US7449456 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide |
| 11/11/2008 | US7449455 1-[4-(2-azepan-1-yl-ethoxy)-benzyl]-2-(4-hydroxy-phenyl)-3-methyl-1H-indol-5-ol; contraception; melanoma; capable of inhibiting bone loss while showing little or no uterine stimulation, decrease the weight gain, decrease cholesterol levels, prevent bone loss |
| 11/11/2008 | US7449454 Metallotexaphyrin derivatives |
| 11/11/2008 | US7449453 Treatment of prostate cancer by administering an azetidinone-based cholesterol absorption inhibitor such as ezetimibe, the phenolic glucuronide of ezetimibe, SCH 48461 or SCH 58053, optionally with an anticancer agent |
| 11/11/2008 | US7449451 Radiation resistance; prevent tissue damage; pretreatment with oxidation resistant |
| 11/11/2008 | US7449450 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products |
| 11/11/2008 | US7449449 Providing microprojectiles carrying polynucleic acid sequences; accelerating the microprojectiles at the preselected-cells, with the microprojectiles contacting cells to penetrate vertebrate cells and deposit polynucleic acid |
| 11/11/2008 | US7449448 Administering fructose of fructose containing oligosaccharide |
| 11/11/2008 | US7449447 Peptidomimetic NS3-serine protease inhibitors of hepatitis C virus |
| 11/11/2008 | US7449446 Synergistic mixture; anticoagulants |
| 11/11/2008 | US7449444 Hydroxyethyl starch-containing polypeptide compositions |
| 11/11/2008 | US7449442 EGFR inhibitors promote axon regeneration |
| 11/11/2008 | US7449321 Controlling a flavivirus entry into a cell by administering to the cell an agent functionally interfering with a flavivirus receptor protein, the flavivirus receptor protein being an integrin |
| 11/11/2008 | US7449315 Bifunctional energy-reversible acyl-compositions |
| 11/11/2008 | US7449236 Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient |
| 11/11/2008 | US7449200 positively charged shell substrate, negatively charged core substrate with encapsulated bioactive agents; for projectile bombardment; composed of chitosan/poly-glutamic acid/insulin or chitosan/poly-glutamic acid/pDNA for transcutaneous delivery |
| 11/11/2008 | US7449198 Stable salts of O-acetylsalicylic acid with basic amino acids |
| 11/11/2008 | US7449197 Liposome formulation of 6,9-bis[(2-aminoethyl)-amino]benzo[g]isoquinoline-5, 10-dione dimaleate |
| 11/11/2008 | US7449196 Anti tumor compositions and methods of use |
| 11/11/2008 | US7449195 Fungicide mixtures |
| 11/11/2008 | US7449175 Delivery of erectile dysfunction drugs through an inhalation route |
| 11/11/2008 | US7449174 Delivery of analgesics through an inhalation route |
| 11/11/2008 | US7449173 heating drugs used for the treatment of anxiety or insomnia, coated on solid supports to form vapors and condensing the vapor to form aerosols comprising microstructure particles of the drugs |
| 11/11/2008 | US7449172 Delivery of antiemetics through an inhalation route |
| 11/11/2008 | CA2588369A1 Methods of treatment and prevention of metabolic bone diseases and disorders |